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Objectives: Joint degeneration in osteoarthritis (OA) is characterised by damage and loss of articular
cartilage. The pattern of loss is consistent with damage occurring only where the mechanical loading is
high. We have investigated using RNA-sequencing (RNA-seq) and systems analyses the changes that
occur in damaged OA cartilage by comparing it with intact cartilage from the same joint.
Methods: Cartilage was obtained from eight OA patients undergoing total knee replacement. RNA was
extracted from cartilage on the damaged distal medial condyle (DMC) and the intact posterior lateral
condyle (PLC). RNA-seq was performed to identify differentially expressed genes (DEGs) and systems
analyses applied to identify dysregulated pathways.
Results: In the damaged OA cartilage, there was decreased expression of chondrogenic genes SOX9,
SOX6, COL11A2, COL9A1/2/3, ACAN and HAPLN1; increases in non-chondrogenic genes COL1A1, COMP
and FN1; an altered pattern of secreted proteinase expression; but no expression of major inﬂammatory
cytokines. Systems analyses by PhenomeExpress revealed signiﬁcant sub-networks of DEGs including
mitotic cell cycle, Wnt signalling, apoptosis and matrix organisation that were inﬂuenced by a core of
altered transcription factors (TFs), FOSL1, AHR, E2F1 and FOXM1.
Conclusions: Gene expression changes in damaged cartilage suggested a signature non-chondrogenic
response of altered matrix protein and secreted proteinase expression. There was evidence of a dam-
age response in this late OA cartilage, which surprisingly showed features detected experimentally in the
early response of cartilage to mechanical overload. PhenomeExpress analysis identiﬁed a hub of DEGs
linked by a core of four differentially regulated TFs.
© 2016 The Authors. Published by Elsevier Ltd on behalf of Osteoarthritis Research Society International.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).Introduction
Osteoarthritis (OA) is a major cause of pain and disability in
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r Ltd on behalf of Osteoarthritis Readdress symptoms and it is important to develop more effective
interventions which reduce disease progression1. OA is a hetero-
geneous disease in which there are multiple mechanisms contrib-
uting to joint failure, including, misalignment/deformity, muscle
weakness, ligament laxity, subchondral bone sclerosis/cysts and
osteophyte formation, but one common outcome is cartilage
damage and loss2.
In OA, the pattern of cartilage damage is typically on the most
loaded tibial and femoral surfaces, whilst other less loaded areas
remain intact. Previous studies have identiﬁed changes in gene
expression in OA cartilage and provided evidence that all OA carti-
lage, including intact cartilage, differs greatly from cartilage on a
healthy joint3. The changes that accompany OA thus affect all joint
cartilage and these changes presumably weaken the tissue such that
it becomes damaged and lost at the sites exposed to greatest
mechanical load. We therefore set up a study to compare cartilagesearch Society International. This is an open access article under the CC BY license
S.L. Dunn et al. / Osteoarthritis and Cartilage 24 (2016) 1431e14401432from intact and damaged sites within the same joint to identify
changes in gene expressionwhich may contribute to intact cartilage
becoming damaged. This paired analysis of samples from the same
joint minimises confounding variables in patient age and genetics
and increases the power of the study4,5. Identifying genes and
regulatory pathways involved asOAcartilage becomesdamagedmay
provide new targets for treatment to delay or reverse the damage.
This study of speciﬁc sites of OA knee cartilage was carried out
using RNA-sequencing (RNA-seq). Compared to microarray tech-
nology this provides a greater dynamic range of analysis with
increased sensitivity and speciﬁcity to provide enhanced identiﬁ-
cation of differentially expressed genes (DEGs). We have also
applied PhenomeExpress, which incorporates cross-species gene-
phenotype associations, to identify dysregulated pathways in
damaged OA cartilage.
Materials and methods
Study design
Cartilage was obtained under Ethics Committee approval with
written informed consent from eight patients with symptomatic
OA at total knee replacement (n ¼ 8, age range 65e79 years, mean
age 70.3). Cartilage from paired osteochondral samples were iso-
lated from the intact posterior lateral condyle (PLC) and the
damaged distal medial condyle (DMC) for RNA-seq analysis (Group
A). An additional group of paired OA samples were used to validate
RNA-seq analysis (n ¼ 8, age range 64e76 years, mean age 69.9)
(Group B). Cartilage was transferred to RNA later for extraction and
RNA-seq and/or reverse transcription quantitative polymerase
chain reaction (RT-qPCR) analysis. Full depth osteochondral blocks
were taken from adjacent sites, ﬁxed in 10% neutral buffered
formalin (SigmaeAldrich) and decalciﬁed in 20% ethyl-
enediaminetetraacetic acid (EDTA).
Histology
De-calciﬁed osteochondral samples were dehydrated in graded
ethanol (Fisher Scientiﬁc) and immersed in xylene (Sigma-
eAldrich). Samples embedded in parafﬁn wax were cut into sec-
tions (5 mm thickness) and stained with 0.1% safranin O-fast green
for histological grading using a modiﬁed Mankin score6. Signiﬁcant
differences were determined using one way analysis of variance
(ANOVA) non-parametric Friedman test.
Sulphated glycosaminoglycan assay (sGAG)
The sGAG content of cartilage tissue from the PLC and DMC was
determined after overnight digestion in papain at 60C using the
dimethylmethylene blue (DMMB) assay with absorbance read at
570 nm7.
RNA extraction
Total RNA was extracted from 200 to 400 mg of cartilage using
TRIzol (LifeTechnologies) reagent and homogenisation (Braun
Mikrodismembrator) following freezing in liquid nitrogen. The RNA
was puriﬁed using RNeasy Qiagen clean-up columns (Qiagen) and
for sequencing had a RIN score of >6 (2200 TapeStation, Agilent
Technologies).
RT-qPCR
cDNA was synthesised from 0.5 to 1 mg of total RNA using MLV
reverse transcriptase and random hexamers (Life Technologies). ForRT-qPCR analysis primer sequences are listed in Supplementary
Table 1. Gene expression was normalised to an average of glycer-
aldehyde 3 phosphate dehydrogenase (GAPDH) and beta actin
(ACTB), which were in the bottom 1% of gene variability in the RNA-
seq results. Relative gene expression levels were determined using
the 2DDCt analysis method8. Differences in expressed genes were
identiﬁed using the non-parametric Wilcoxon signed-ranked test
where P-values 0.05 were considered signiﬁcant. Statistical
analysis was with GraphPad Prism version 6.04.
RNA-seq
Strand speciﬁc RNA-seq libraries were generated from 0.5 to
1 mg RNAusing the TruSeq® StrandedmRNA Sample Preparation Kit
(Illumina, Inc.) and 101 bp paired-end reads were generated,
yielding at least 39 million reads per sample. The fastq ﬁles
generated by HiSeq Illumina 2000 platform were analysed with
FastQC and scanned against other genomes for possible contami-
nation. Low quality reads, contaminated barcodes and primers
were further trimmed with Trimmomatic9,10. All libraries were
aligned to hg19 assembly of human genome using Tophat-2 with
the best score matches reported for each read11. The mapped reads
were counted by genes with HTSeq against gencode v16 to reﬂect
gene abundance11,12. Inter gene expression comparisons were
based on calculated fragments per kilobase of transcript per million
mapped reads (FPKM). Within the 16 datasets reads from 33,960
(60%) of 56,562 human genes in gencode v16 were detected.
Following removal of those with lowest reads, to optimise detec-
tion of DEGs, the analysis was on 17,160 genes.
A standard method for estimation of fold change and dispersion
for RNA-seq data (DESeq2) was used to initially identify DEGs13.
The false discovery rate for the analysis (10%) was selected to
provide the maximum number of DEG (1575 DEG) with a reason-
able level of conﬁdence to best inform the subsequent analysis. For
comparison, a lower false discovery rate 5%, gave 1375 DEG
(identiﬁed in red in Supplementary Table 2, Sheet 2). The 5000
genes with most signiﬁcant changes by P-value were removed and
the remaining genes used as in silico negative controls for batch
effect factor calculation with RUVg14. DESeq2 was then used with
batch correction to identify DEGs. The resulting P-values were
adjusted for multiple testing with BenjaminieHochberg (BH)
correction. Data access to R code to reproduce the bioinformatics
analysis is at https://github.com/soulj/Dunnetal2015. The RNA-seq
data is available from ArrayExpress (E-MTAB-4304).
Comparison with previous microarray studies
To compare the results with two microarray studies of damaged
and intact OA cartilage4,5, the dataset GSE57218 was downloaded
fromGene Expression Omnibus and Snelling et al. provided the raw
data from their study4,5,15. Both array datasets were analysed as
previously reported4,5. DEGs in all datasets were deﬁned with 1.5
fold change and an adjusted P-value of 0.1, which are thresholds
used commonly for transcriptomic analysis16,17. Hyper-geometric
overlap statistics were used to calculate probability of the
observed overlap of DEGs.
PhenomeExpress sub-network identiﬁcation
PhenomeExpress was used with proteineprotein, phenoty-
peephenotype and proteinephenotype networks created; to
identify groups of interacting DEGs related to OA phenotypes21.
With a maximum initial sub-network size of 7, an empirical P-value
threshold of 0.05 was used to ﬁlter sub-networks by random
sampling (10,000 sub-networks) of the ﬁltered PPI network.
S.L. Dunn et al. / Osteoarthritis and Cartilage 24 (2016) 1431e1440 1433Phenotypes relevant to OAwere chosen on the basis of the web tool
Phenomiser and throughmanual search of the UberPheno ontology
(HP:0005086, HP:0001387, MP:0003724 and MP:0003436)22.
Identiﬁcation of upstream transcription factors (TFs)
The iRegulon framework was used to produce a ranked list of
cross-species motif-cluster occurrences in gene promoters as pre-
viously described23. Brieﬂy, Human promoters (2000 bp upstream,
200 bp downstream of transcriptional start sites) and orthologous
regions from Chicken, Chimp, Cow, Dog, Mouse, Rat and Zebraﬁsh
were scored using ClusterBuster and then aggregated into a ranked
list of target genes for each motif with the RobustRankAggreg
Bioconductor package24,25. Motifs were then annotated to TFs using
a motif-TF network23. Chip-seq data from ENCODE and ReMap was
used to produce ranked lists of target genes for each TF by the
enrichment score26,27. Text-mining based TF to gene regulatory
interactions were derived from the EVEX database28. Coexpression
data was taken from CoExpressDB for human experiments across
GEO and genes were ranked for each TF by correlation29. The
differentially expressed upregulated or down-regulated geneswere
then used to ﬁnd the enriched upstream TFs using the iRegulon
approach of AUC recovery for each motif/TF (z-score 3) or using
hyper-geometric statistics in the case of the text-mining in-
teractions (BH-adjusted P-value 0.1). The DEGs predicted to be
regulated by these TFs were recovered as previously described23.
Results
Histology and glycosaminoglycan (GAG) content of the articular
cartilage
To characterise the cartilage tissue, the paired OA samples were
graded histologically using a modiﬁed Mankin score6. This
conﬁrmed that the cartilage obtained from the DMC (mean ± SD
20.1 ± 0.67) was signiﬁcantly more damaged than the cartilageFig. 1. Histological grading and GAG content of OA articular cartilage. Safranin O stainin
score of the articular cartilage (C) and GAG content of the cartilage tissue (D) obtained from
for validation (n ¼ 16). Images acquired using a [20/0.80 Plan Apo] objective using the
**P < 0.01.obtained from the PLC (9.75 ± 0.62) (P< 0.0001) [Fig.1(A)e(C)]. The
GAG content was 19.5% lower in the DMC cartilage (P < 0.01)
[Fig. 1(D)].
DEGs
RNA-seq analysis was performed on the eight paired OA DMC
and PLC samples and after normalisation and correction for mul-
tiple testing we identiﬁed 830 genes signiﬁcantly upregulated and
745 genes signiﬁcantly down-regulated (4.8 and 4.3% respectively
of the total genes analysed) in the damaged cartilage relative to the
intact (Supplementary Fig. 1) (full list in Supplementary Table 2).
The top upregulated genes with associations to OA or cartilage/
chondrocyte biology included; LIF (6.51 fold), TNFAIP6 (TSG-6)
(4.67 fold), SERPINE1 (3.94 fold), VCAN (3.46 fold) and WISP1 (3.30
fold) (Supplementary Table 3) and the most down-regulated genes
included; TAC1 (3.35 fold), IGF2 (2.77 fold) and VIT (2.43 fold)
(Supplementary Table 4).
Matrix protein gene expression changes
As the integrity of thematrix is clearly important in OA cartilage,
it was noticeable that many extracellular matrix (ECM) genes were
amongst the most highly expressed genes in both DMC and PLC
samples (22 of the top 50), suggesting both sites have strongmatrix
production. Comparing the two sites the expression of speciﬁc
matrix protein genes were increased in the damaged cartilage, but
it suggested a change in matrix forming phenotype, as those
increased were more associated with non-chondrogenic cells.
These included COL1A1 (2.64 fold), FN1 (1.82 fold), COMP (1.48
fold), POSTN (2.99 fold), LAMB3 (3.19 fold), TGFBI (TGFb induced
protein) (2.33 fold) and four highly expressed small leucine rich
proteoglycans (SLRPS); LUM (2.21 fold), OGN (2.13 fold), ASPN (2.08
fold) and DCN (1.27 fold), whereas there was decreased expression
of chondrocyte associated genes: SOX9 (1.46 fold), SOX6 (1.71
fold), ACAN (1.63 fold), COL9A1 (2.25 fold), COL9A2 (1.98 fold)
COL9A3 (1.84 fold), COL11A2 (2.06 fold) and HAPLN1 (1.77g of the PLC (A) and DMC (B) of representative OA patient samples. Modiﬁed Mankin
the PLC and the DMC and used for RNA-seq analysis and an independent patient cohort
3D Histech Pannoramic 250 Flash II slide scanner. Magniﬁcation 5. ****P < 0.0001,
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and although there was a small decrease in damaged cartilage, this
was not signiﬁcant. Genes involved in the collagen biosynthesis
pathway, LEPREL1 (prolyl 3-hydroxylase2 2.39 fold), P4HA3 (prolyl
4-hydroxylase alpha polypeptide3, 1.92 fold), LOX (1.44 fold lysyl
oxidase) and LOXL1 (1.77 fold lysyl oxidase-like 1) were also
increased in damaged cartilage (Supplementary Table 2). These
ECM protein results suggested a co-ordinated, but not chondro-
genic response in the damaged cartilage.
Changes in cytokines, proteinases and their inhibitors
The expression of the pro-inﬂammatory cytokines often asso-
ciated with OA, including IL-1a/b, IL-6, OSM and TNFa, was barely
detected and well below the cut-off used for the analysis (see
Methods). There was low but detectable expression of IL-11, which
was 2.4 fold increased in damaged and expression of IL-16, but this
was unchanged in damaged. Some of the matrix degrading en-
zymes associated with cartilage degradation in OA such as MMP-1,
MMP-13 and ADAMTS-4 were not differentially expressed between
damaged and intact sites, but ADAMTS-1 (1.77 fold) 2 (1.47
fold) 5 (2.38 fold), 6 (2.33 fold), 12 (1.81 fold), 14 (3.74 fold)
and HTRA1 (2.08 fold) were increased and although TIMP-1 was
unchanged, TIMP-2 (1.32 fold), TIMP-3 (1.62 fold) and TIMP-4 (1.41
fold) were all increased. In contrast, MMP-3 (1.49 fold) gene
expression was decreased in the damaged cartilage, as has been
previously reported in OA cartilage damage. Results from the RNA-
seq data were conﬁrmed by RT-qPCR for selected chondrocyte
associated genes, which showed similar results to the RNA-seq in
the same eight patients (Group A) and in a separate group of eight
additional (Group B) OA patients (Table I).
Study comparisons
A comparison of our results with two previous paired damaged
and intact OA cartilage studies based on microarrays found statis-
tically signiﬁcant overlap between the DEGs (3.98  1037 and
9.61  1032 with the Ramos et al. and Snelling et al. datasets,
respectively). We identiﬁed 22 gene changes (fold change 1.5,
adjusted P-value 0.1) that were common in all three studies4,5
[Fig. 2(A) and (B)]. Genes know to be associated with cartilage
biology and OA including CRLF1, PTGES, SERPINE2, TNFAIP6 (TSG-6)
and TNFRSF11B (osteoprotegerin) all increased in expression and
FRZB and VIT decreased in the expression [Fig. 2(B)]. Individual
comparisons between studies are shown in Supplementary Fig. 3.
Differentially regulated sub-networks
We recently described a method, PhenomeExpress, of tran-
scriptomic analysis, in which known gene association with diseaseTable I
Real-time PCR validation of RNA-seq analysis. (NS ¼ not signiﬁcant P > 0.05)
Gene name RNA-seq Real-time PCR validation
RNA-seq (group A, n ¼ 8)
FC Adj P-val FC P-val
TNFAIP6 4.67 1.9  1019 6.91 7.8  10
TNFRSF11B 2.54 3.2  1005 2.60 0.02
COL1A2 1.52 0.2 (NS) 1.81 7.8  10
HAPLN1 1.77 1.5  1005 2.28 0.02
FRZB 2.05 9.2  1007 2.64 0.02
COL2A1 1.29 0.4 (NS) 1.51 0.06 (NS)
ACAN 1.63 9.3  1004 2.08 7.8  10
SOX9 1.46 2.2  1005 1.82 7.8  10is combined with knowledge of proteineprotein interaction net-
works to identify differentially regulated sub-networks enriched in
genes associated with the disease phenotype21. PhenomeExpress
analysis on the paired OA RNA-seq data identiﬁed 23 differentially
regulated sub-networks enriched in OA phenotype related proteins
(Table II). Sub-networks with genes linked to OA included ECM
organisation, mitotic cell cycle, regulation of transcription,
apoptosis andWnt signalling [Fig. 3]. Themitotic cell cycle pathway
included increases in cell cycle regulatory genes CDK1, CEP55,
TOP2A and the alarmin S100A4 [Fig. 3(A)]. The regulation of TF
pathway gave further evidence of a decrease in gene expression
associated with the chondrocyte phenotype; with less expression
of SOX9, ETS1, ETS2 andMAF [Fig. 3(B)]. AlteredWNTsignallingwas
identiﬁed in the damaged cartilage, with increases in WNT5A and
FZD1 and decreases in FZD2 and ROR2 genes [Fig. 3(C)]. Apoptotic
processes were found to be dysregulated in the damaged cartilage,
with increased expression of multiple members of the tumour
necrosis factor receptor superfamily; TNFRSF11B (osteoprotegerin),
TNFSF10 (trail or CD253), TNFRSF12A (tweak receptor) and
TNFRSF4 (CD134, or OX40) [Fig. 3(D)]. The negative blood coagu-
lation pathway, included the strongly expressed members of the
serine proteinase inhibitor superfamily, SERPINE1 (1.98 fold) and
SERPINE2 (2.84 fold), but the less expressed proteases, PLAT (tissue
plasminogen activator, 2.19 fold) and PLAUR (urokinase, 2.02 fold)
were also increased [Fig. 3(E)]. Changes in the ECM organisation
pathway were associated with increases and decreases in multiple
matrix protein genes as noted above [Fig. 3(F)]. All other Pheno-
meExpress networks can be found in Supplementary Fig. 2.Upstream TFs
We next sought to identify upstream regulators that may
explain the observed DEGs and investigate their link to dysregu-
lated biological processes identiﬁed with PhenomeExpress. Anal-
ysis of the regulatory elements of the DEGs based on (1) TF binding
motifs, (2) chip-seq, (3) text-mining and (4) coexpression results
identiﬁed four TFs (each selected by at least two of the above
criteria) controlling their expression (Supplementary Table 5).
Further analysis of these four factors (FOXM1, FOSL1, E2F1 and
AHR) identiﬁed strong regulatory interactions between the Phe-
nomeExpress analysis pathways in damaged OA cartilage
(P ¼ 6.14  1025) [Fig. 4]. Furthermore out of the 830 upregulated
genes identiﬁed by RNA-seq analysis, 360 were found to be regu-
lated by at least one of the four TFs. Amongst these genes are those
with negative associations to chondrocyte biology, including
COL1A1, COL7A1, and VCAN, which showed interactionswith FOSL1
and AHR; genes in the apoptosis pathway, including tumour ne-
crosis factor receptor superfamily genes; TNFSF10, TNFRSF11B,
TNFRSF12A, which showed interactions with AHR and FOXM1of Real-time PCR validation on
independent patent cohort
(group B, n ¼ 8)
Combined real-time PCR
validation (group A þ B,
n ¼ 16)
FC P-val FC P-val
03 2.86 0.02 4.45 <1.0  1004
3.13 7.8  1003 2.85 <1.0  1004
03 1.55 0.3 (NS) 1.67 7.6  1003
2.19 0.02 2.25 2.0  1003
3.35 7.8  1003 2.97 2.0  1003
1.17 0.4 (NS) 1.33 0.03
03 1.47 7.8  1003 1.75 8.0  1003
03 1.32 0.3 (NS) 1.55 0.02
Fig. 2. Comparison of intact vs damaged OA cartilage transcriptome studies. Overlap of DEGs identiﬁed by the RNA-seq data and the two existing microarray datasets Snelling
et al. and Ramos et al. (A). The log2 fold change of the 22 DEGs in the three compared datasets (B).
S.L. Dunn et al. / Osteoarthritis and Cartilage 24 (2016) 1431e1440 1435[Fig. 4] and a large proportion of the genes associated with the
mitotic cell cycle, which had regulatory links to all four differen-
tially expressed TFs [Fig. 4].
Discussion
OA is a complex and heterogeneous disease and by investigating
the differences between damaged and intact cartilage in a group of
OA patients at joint replacement, we hoped to identify active pro-
cesses that may help explain why damage is progressive and does
not lead to successful repair. As the two cartilage sites are in the
same joint compartment they are likely to share systemic and
locally generated soluble factors, but clearly do not share the samepattern of mechanical load. We therefore propose that the differ-
ences between the intact and damaged cartilage reveals how OA
cartilage responds to excess load and its consequences as the
cartilage is damaged and lost. The changes reported are not
therefore interpreted as symptomatic of OA, but they identify the
changes in cartilage that underlie its damage.
A major feature of our current RNA-seq analysis is that it helps
ﬂesh out the complex pattern of changes in matrix protein gene
expression. These changes appear to predict a general decline in
differentiated chondrocyte function and the upregulation of matrix
genes associated with non-chondrogenic cells. This suggests that
the signals governing chondrocyte function in the area of damage
are driving responses that are not chondrogenic and do not succeed
Table II
Summary of PhenomeExpress networks. Differentially regulated sub-networks related to OA phenotypes. The size, empirical P-value and the top enriched gene ontology
biological process term is indicated for each network
Network number Network size Empirical P-value Top GO biological process
A 37 0.0001 Mitotic cell cycle
B 6 0.0214 Positive regulation of transcription from RNA polymerase II promoter
C 4 0.0117 Wnt signalling pathway, calcium modulating pathway
D 15 0.0032 Apoptotic process
E 20 0.0001 Negative regulation of blood coagulation
F 25 0.0001 ECM organization
G 5 0.0228 Pyridine-containing compound biosynthetic process
H 6 0.0014 Anterior/posterior axon guidance
I 7 0.0016 Organ morphogenesis
J 4 0.0087 Regulation of Ras GTPase activity
K 4 0.0143 O-glycan processing
L 8 0.0098 Chromosome condensation
M 4 0.0094 Ovarian cumulus expansion
N 15 0.0002 ER-associated ubiquitin-dependent protein catabolic process
O 6 0.0065 Calcineurin-NFAT signalling cascade
P 7 0.0134 Acetylcholine secretion, neurotransmission
Q 8 0.0006 Positive regulation of tyrosine phosphorylation of Stat3 protein
R 8 0.0129 Regionalization
S 6 0.049 CAAX-box protein processing
T 7 0.008 Rhombomere formation
U 5 0.0196 Positive regulation of receptor recycling
V 5 0.0114 Hepatocyte growth factor receptor signalling pathway
W 5 0.0089 Response to lipopolysaccharide
S.L. Dunn et al. / Osteoarthritis and Cartilage 24 (2016) 1431e14401436in stabilising the cartilage matrix to resist further damage. The
problem in the damaged cartilage is therefore not a lack of matrix
gene expression, but the production of the wrong type of me-
chanically weak matrix. With the potential to contribute to this
response is increased expression of several anabolic growth factors,
including high levels of CTGF, which is associated with ﬁbrosis in
wound healing and in cartilage matrix remodelling and lesser in-
creases in FGF1, FGF2, TGFB1, TGFB3, BMP2 and BMP630. This
growth factor expression might offset the effects of processes such
as inﬂammation from inﬂammatory cytokines, which have for long
been characterised in vitro as blocking synthesis and driving
degradation of cartilage. However, our analysis in eight OA patients
showed that the expression of IL-1a/b, OSM and TNFa was barely
detected in either intact or damaged cartilage. This is in general
agreement with other studies reporting that these inﬂammatory
cytokines are not expressed in human OA cartilage in vivo and from
other genome wide analysis, which reports little evidence for a
prominent role for them in OA31e33.
Although these matrix gene expression changes do not appear
to be driven by chondrocyte expression of IL-1a/b, OSM or TNFa,
there is some evidence of chondrocyte inﬂammatory response with
increased expression of TNFAIP6 (TSG-6), PTGES and iNOS in the
damaged cartilage. Whilst the low expression IL-16 and increase in
IL-11 may contribute to this, together with the low levels of in-
ﬂammatory cytokines reported in some OA synovial ﬂuids34e36, a
mechanism that may bemore active in the damaged cartilage is the
production of various damage-associated molecular pattern
(DAMPS) arising from increased proteolytic products of matrix
proteins32. A leading candidate substrate for DAMPS production is
ﬁbronectin, which our results show is very highly expressed and
further increased in damaged cartilage and ﬁbronectin fragments
are reported to stimulate intracellular S-sulfenylation, which may
drive matrix damage pathways37. Other possible DAMPS include
fragments of ﬁbromodulin, COMP, tenascin C together with
aggrecan fragments such as the 32mer, which may all be active in
eliciting the increased responses we detect speciﬁcally in the
cartilage exposed to the greatest load32,38.
In assessing which proteinases might be responsible for
increased DAMPS production at the DMC site, there was littlechange in most MMP enzyme expression and furthermore the
important MMP inhibitors TIMP2, 3 and 4 were all increased in
expression. However, there was some increase in ADAMTS-1 and
-5, which both have aggrecanase activity and in ADAMTS-2 and -14,
which are procollagen aminopeptidases and in other ADAMTS en-
zymes with less clear substrates (ADAMTS-6 and -12). There was
also an increase in the already highly expressed serine proteinase
HTRA1, which is associated with pericellular matrix remodelling in
OA animal models39. These proteinases may be active in generating
DAMPS that drive other downstream changes. This proﬁle of pro-
teinase expression suggests an altered response of the chon-
drocytes that is quite distinct from that induced by inﬂammatory
cytokines and not historically linked with cartilage degradation.
This altered pattern of both matrix gene expression and proteinase
expression may be the signature of cartilage damage in the OA
joint. It is therefore proposed that a major response of OA cartilage
is to remodel matrix abnormally at major loading sites. However, it
remains to be determined what causes the changes in gene
expression, which are localised to the damaged OA cartilage, to be
non-chondrogenic and why they fail to sustain the function of the
tissue in the mechanically loaded environment.
The comparison of the results with two other studies on
damaged and intact cartilage identiﬁed some common changes in a
broader human OA context. The study of Snelling et al.was on tibial
OA cartilage, whereas that of Ramos et al. was on hip and knee OA
cartilage4,5. However, despite the different cartilage sources and
analytical methods for the three studies, a core of 22 common gene
expression changes were identiﬁed, which showed that many
changes are common to cartilage at damage sites in different joints
and that these studies also detected elements of the OA signature
responses, which we now highlight in this study.
PhenomeExpress provides a comprehensive overview of the
processes dysregulated in the damaged cartilage of an OA joint
using the knowledge gained from natural disease and animal
models. Combining this with computational analysis of the pro-
moters of DEGs identiﬁed four differentially expressed TFs with
links to a large proportion (360 of 830) of DEGs in damaged carti-
lage. Although they have not previously been studied in OA, E2F1,
AHR and the AP1 family member FOSL1 (also known as Fra-1) are
Fig. 3. PhenomeExpress analysis. Network analysis incorporating cross-species gene-phenotype associations, identiﬁed 23 differentially expressed networks based on direct
proteineprotein interactions in the damaged cartilage. Sub-networks linked to OA included; mitotic cell cycle (P ¼ 0.0001) (A), regulation of transcription (P ¼ 0.021) (B), Wnt
signalling and calcium modulating pathway (P ¼ 0.0102) (C), apoptotic processes (P ¼ 0.0056) (D), negative regulation of blood coagulation (P ¼ 0.0001) (E) and ECM organisation
(P ¼ 0.0001) (F). The fold change of the proteins is shown by the node colour and OA associated phenotype annotated proteins used to generate the sub-networks are shownwith a
black border.
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is a regulator of the cell cycle40e43. Interestingly, FOSL1 was found
to be activated in loaded mandibular cartilage, suggesting its
expression may be one of the responses to mechanical load in the
DMC44. Although, identiﬁed as regulating the DEGs independently,
these four TFs are also predicted to regulate one another, suggesting
a complex regulatory cascade. Furthermore, the target genes of the
four TFs had a statistically signiﬁcant overlap with the genes pre-
sent in the PhenomeExpress pathways, suggesting these four TFs
may play a critical role in regulating the perturbed cellular path-
ways, such as altered ECM turnover induced in the damaged
cartilage.A limitation of this study is that only eight patients were
investigated and therefore it detects only the most common
changes. It is also based on transcription and in some cases gene
expression may not be tightly linked to protein expression and
regulation at the post translational level, such that changes in ac-
tivity of enzymes such as kinases, or in processes, such as pro-
teinase activation, or proteosomal degradation, may go undetected.
It will also not report on factors thatmay inﬂuence gene expression,
including microRNAs and mRNA stability45. The transcriptomic
analysis of chondrocytes thus provides evidence of processes acti-
vated and inhibited in damaged cartilage, but it is undoubtedly
biased to those with a strong genotypic signature.
Fig. 4. Multi-layered architecture of damaged OA cartilage signalling. Network showing regulatory interactions between the differentially expressed, predicted upstream TFs and
the PhenomeExpress identiﬁed pathways in damaged OA cartilage. Transcriptional links between the four upstream TFs are shown with grey arrows. Regulatory links between the
TFs and signiﬁcantly upregulated target genes present in PhenomeExpress pathways are shown red, green, pink and blue for FOSL1, AHR, E2F1 and FOXM1 respectively. The
PhenomeExpress pathways are named by the top enriched GO biological process term. Only PhenomeExpress pathways with at least two target genes present are shown.
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damaged OA cartilage are similar to the reported early responses of
cartilage to mechanical loading, such as in joint destabilization
(DMM) models of OA46e48. They include early upregulation of Wnt
signalling with increased gene expression of several Wnt proteins
(5A, 5B, 7B, 9A and 16), increased WISP1 and downstream targets
such as osteoprotegerin and down regulation of Wnt antagonists
FRZB and DKK1. There was also increases [Fig. 3] associated with
cell proliferation, in altered matrix protein expression, particularly
in collagen genes and collagen processing enzymes. Chondrocyte
response to mechanical loading therefore appears as one of the
drivers of responses in damaged OA cartilage. Whether it is the
major factor, or just one of many factors responsible for the altered
matrix gene andmatrix proteinase expression noted above remains
to be assessed. What is surprising is that these responses to
“loading” of cartilage are still detected at joint replacement and
therefore may have persisted in damaged OA cartilage over many
years. Much discussion of mechanisms driving cartilage damage in
OA has assumed that there are distinct phases that distinguish
“early OA” from “late OA”. It is intriguing that some early responses
may continue to be active over many years throughout the
degenerative process and may therefore provide targets for inter-
vention throughout the clinical progression of OA.
This study identiﬁes from a detailed transcriptional analysis of
damaged and intact OA cartilage, evidence for; (1) signature
changes in the gene expression of matrix protein and secreted
proteinases that may contribute to the progressive damage; (2)
changes in late-stage damaged OA cartilage, which are similar to
short term responses detected in the DMMmouse model of OA; (3)
identiﬁcation of four TFs in damaged cartilage forming a hub
linking multiple regulatory changes identiﬁed by PhenomeExpress.Authors' contributions
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